Semi-annual Report for 2026
Filed with SSE · · 165 pages · Chinese
Earlier from Guobang Pharma
- Announcement on Progress in Repurchasing Shares
- Announcement on the Repurchased Company Shares Reaching 1% and Repurchase Progress
- Announcement on Wholly-owned Subsidiary Participating in Equity Investment Fund
- Announcement on Initially Repurchasing the Company's Shares through Auction
- Announcement on Shareholding of Top 10 Shareholders and Top 10 Shareholders Without Sales Limit Concerning Shares Repurchase
Later from Guobang Pharma
- Announcement on Convening the 2026 Semi-annual Performance Briefing
- Announcement on a Wholly-owned Subsidiary's Product DMG-PEG2000 Passing the Joint Review and Approval with Its Formulation by the CDE
- Announcement on Obtaining New Veterinary Drug Registration Certificate by Wholly-owned Subsidiary
- (605507)"Guobang Pharma Ltd."Announcement on Progress in Repurchasing Shares
- (605507)"Guobang Pharma Ltd."Announcement on Change of Name and Other Industrial and Commercial Information of the Controlling Shareholder and Completion of Industrial and Commercial Registration Changes
Follow Guobang Pharma into a list and get an email when it puts out news.
Follow Guobang Pharma